MicroRNA to combat cancer

September 28, 2010

(PhysOrg.com) -- Researchers from the Queensland Institute of Medical Research, the Garvan Institute of Medical Research and the University of California-San Francisco have found a new way to kill cancer cells, opening the way for a new generation of cancer treatments.

By blocking the function of a type of genetic material called microRNA, researchers have dramatically decreased the size of a in a mouse model.

“MicroRNAs originate from part of our DNA that has long been thought of as . Much is still unknown but we know they can interfere with the functioning of genes and can control the production of proteins in the body,” said QIMR researcher Dr Susan Woods.

“A lot of research has focused on a protein called p53 that acts as a natural defence again cancer. Without p53, a normal cell can multiply out of control - in other words become cancerous.”

“We chose to study a particular type of cancer called neuroblastoma, which is a childhood cancer of the nervous system. We found that these cancers disable p53 by over-producing the microRNA that we study. This results in a reduction in the amount of protection against cancerous changes in that cell - leading to the growth of tumours.

“However when we blocked the microRNA, production resumed, the died and the tumours became much smaller.”

MicroRNA inhibitors have been readily available for use in the laboratory for about the last five years.

“What is really exciting about this research is it is the first time that anyone has blocked the growth of a primary tumour by the simple delivery of a microRNA inhibitor.”

“While this finding is at an early research stage, our results indicate that this microRNA is a potential for future treatment of early childhood neuroblastomas and other microRNA-induced cancers.”

The study was done in collaboration with the Garvan Institute of Medical Research, Victor Chang Cardiac Research Institute, St Vincent’s Clinical School, University of New South Wales, The Children's Hospital at Westmead, Regulus Therapeutics, University of Texas, and University of California-San Francisco.

The study is published today in the journal Nature Medicine and is available online dx.doi.org/10.1038/nm.2227

Related Stories

Recommended for you

Bone marrow protein a 'magnet' for passing prostate cancer cells

September 19, 2017
Scientists at the University of York have shown that a protein in the bone marrow acts like a 'magnetic docking station' for prostate cancer cells, helping them grow and spread outside of the prostate.

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

Brain cancer breakthrough could provide better treatment

September 19, 2017
A new discovery about the most common type of childhood brain cancer could transform treatment for young patients by enabling doctors to give the most effective therapies.

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

Altitude training for cancer-fighting cells

September 18, 2017
Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions. It turns out that cancer-fighting cells of the immune system ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

deandreaoats
not rated yet Sep 28, 2010
Wow really good step this is for combat cancer.
http://ultragrowt...ork.html
TabulaMentis
not rated yet Sep 28, 2010
When scientists say "microRNA" are they talking about specially designed viroids or viruses being used as the silver bullet?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.